Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?

Jyoti D. Patel*, Steven J. Chmura

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)2878-2880
Number of pages3
JournalCancer
Volume124
Issue number14
DOIs
StatePublished - Jul 15 2018
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this